Elucidating the inhibitory effects of rationally designed novel hexapeptide against hen egg white lysozyme fibrillation at acidic and physiological pH
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2023
DOI: 10.1016/j.bbapap.2023.140899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2023. Verfasst von Amit Mitra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela 769008, Odisha, India. Hauptthemen laut MEDLINE: Muramidase, Protein Aggregates. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Institute of Technology Rourkela.
Abstract (Originalsprache)
Inhibition of highly ordered cross-β-sheet-rich aggregates of misfolded amyloid proteins using rationally designed sequence-based short peptides is a promising therapeutic strategy for the treatment of neurodegenerative diseases. Here, we have explored the anti-amyloidogenic potency of a rationally designed hexapeptide (Tyr-Pro-Gln-Ile-Pro-Asn) on in vitro hen egg white lysozyme (HEWL) amyloid fibril formation at acidic pH and physiological pH using computational docking as well as various biophysical techniques such as fluorescence spectroscopy, UV-vis spectroscopy, FTIR spectroscopy, confocal microscopy and TEM. The peptide was designed based on the aggregation-prone region (APR) of HEWL and thus referred to as SqP1 (Sequence-based Peptide 1). SqP1 showed over 70% inhibition of HEWL amyloid formation at pH 2.2 and approximately 50% inhibition at pH 7.5. We propose that SqP1 binds to the APR of HEWL and interacts strongly with the Trp62/Trp63, ultimately stabilizing monomeric HEWL at both the pH conditions and preventing conformation changes in the structure of HEWL, leading to the formation of amyloidogenic fibrillar structures. A sequence-based peptide inhibitor of HEWL amyloid formation was not reported previously, making this a critical study that will further emphasize the importance of short synthetic peptides as amyloid inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela 769008, Odisha, India.
- Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela 769008, Odisha, India. Electronic address: sarkarn@nitrkl.ac.in.
Förderung
- National Institute of Technology Rourkela
Zitieren
APA
Mitra, A., & Sarkar, N. (2023). Elucidating the inhibitory effects of rationally designed novel hexapeptide against hen egg white lysozyme fibrillation at acidic and physiological pH. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. https://doi.org/10.1016/j.bbapap.2023.140899
Vancouver
Mitra A, Sarkar N. Elucidating the inhibitory effects of rationally designed novel hexapeptide against hen egg white lysozyme fibrillation at acidic and physiological pH. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2023. doi:10.1016/j.bbapap.2023.140899
BibTeX
@article{Mitra2023,
author = {Mitra, Amit and Sarkar, Nandini},
title = {Elucidating the inhibitory effects of rationally designed novel hexapeptide against hen egg white lysozyme fibrillation at acidic and physiological pH},
journal = {Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics},
year = {2023},
doi = {10.1016/j.bbapap.2023.140899}
}
EUVIMED